BioCision Announces Two New U.S. Patents for Thermo-Conductive Products
News Jun 20, 2013
BioCision has announced the issuance of new patents by the U.S. Patent Office that apply to two of the company’s thermo-conductive products developed to standardize sample handling to ensure the consistency of test conditions and accuracy of results in common laboratory procedures.
Patent number 8,388,912 covers CoolSink® Plate Modules, which provide a solid, sturdy interface between laboratory sample plates and a heat sink, such as ice, or a heat source.
The modules are made of a thermo-conductive alloy that maintains an even temperature across all wells in the plate, eliminating any “edge effect” where content from the wells close to the perimeter of the plate change temperature more rapidly than those in the center of the plate.
This helps maintain samples at a desired temperature while keeping them dry and sterile, which are optimal conditions for ELISA, multiplex immunoassays, enzyme assays, and cell washing steps.
In addition, BioCision’s ThermalTray™ Platforms were awarded patent number 8,460,621. The platforms support sample racks or plates in liquid and semi-solid heat sinks and sources such as melting ice, water baths, and liquid nitrogen.
Eliminating direct contact between a sample tube or plate and melting ice or bath water protects against potential water-borne contaminants.
The platforms are made of a thermo-conductive alloy, assisting in the transfer of heat between samples and a temperature source.
“These new patents reflect the innovation and new opportunities to improve sample standardization that our products represent,” said Rolf Ehrhardt, MD, PhD, BioCision CEO.
Ehrhardt continued, “This patent protection provides significant support for our continuing efforts to help research institutions in the biotechnology, pharmaceutical, clinical, diagnostic, academic, and government scientific communities to set entirely new standards for performance in sample handling.”
Ensuring reproducible temperature profiles and standardizing temperature-sensitive lab procedures are essential goals in a wide array of scientific disciplines, including cell and tissue culture, cryopreservation, histology, immunohistochemistry, virus and bacterial research, molecular biology, cell therapy, pharmaceutical manufacturing, biofuels research and many others.
Advances in technology to control temperature in sample handling can improve accuracy of test results, which can have a direct impact on diagnosis and patient outcomes.
In addition, improvements in sample standardization can improve the ability of researchers around the world to replicate important research results.
Large-Scale Production of Living Brain Cells Enables Entirely New ResearchNews
After performing a biopsy on the patient, the skin cells are transformed into brain cells that effectively imitate the disease and the age of the patient.READ MORE
Innate Reaction of Hematopoietic Stem Cells to Severe InfectionsNews
Researchers at the University of Zurich have shown for the first time that hematopoietic stem cells detect infectious agents themselves and begin to divide, without signals from growth factors.READ MORE
CRISPR Reveals New Targets for Promising Cancer DrugsNews
Novel screening method identifies new drug targets that could potentially enhance the effectiveness of PD-1 checkpoint inhibitors, a promising new class of cancer immunotherapy.READ MORE
Comments | 0 ADD COMMENT
EMBL Course: Transgenic Animals - Micromanipulation Techniques
Apr 10 - Apr 11, 2018
EMBO Practical Course: Extracellular Vesicles: From Biology to Biomedical Applications
Apr 09 - Apr 13, 2018